annual FCF:
-$273.69M+$48.59M(+15.08%)Summary
- As of today (September 16, 2025), TVTX annual free cash flow is -$273.69 million, with the most recent change of +$48.59 million (+15.08%) on December 31, 2024.
- During the last 3 years, TVTX annual FCF has fallen by -$234.74 million (-602.79%).
Performance
TVTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$7.34M+$46.64M(+86.41%)Summary
- As of today (September 16, 2025), TVTX quarterly free cash flow is -$7.34 million, with the most recent change of +$46.64 million (+86.41%) on June 30, 2025.
- Over the past year, TVTX quarterly FCF has increased by +$44.90 million (+85.95%).
- TVTX quarterly FCF is now -127.49% below its all-time high of $26.69 million, reached on September 30, 2021.
Performance
TVTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$157.30M+$44.90M(+22.21%)Summary
- As of today (September 16, 2025), TVTX TTM free cash flow is -$157.30 million, with the most recent change of +$44.90 million (+22.21%) on June 30, 2025.
- Over the past year, TVTX TTM FCF has increased by +$160.47 million (+50.50%).
Performance
TVTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TVTX Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +15.1% | +86.0% | +50.5% |
3 y3 years | -602.8% | +84.8% | -37.7% |
5 y5 years | -271.0% | +32.6% | -120.1% |
TVTX Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -602.8% | +15.1% | at high | +94.2% | -37.7% | +53.5% |
5 y | 5-year | -602.8% | +15.1% | -127.5% | +94.2% | -436.2% | +53.5% |
alltime | all time | <-9999.0% | +15.1% | -127.5% | +94.2% | <-9999.0% | +53.5% |
TVTX Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$7.34M(-86.4%) | -$157.30M(-22.2%) |
Mar 2025 | - | -$53.98M(+19.2%) | -$202.19M(-26.1%) |
Dec 2024 | -$273.69M(-15.1%) | -$45.28M(-10.7%) | -$273.69M(-10.1%) |
Sep 2024 | - | -$50.70M(-2.9%) | -$304.41M(-4.2%) |
Jun 2024 | - | -$52.24M(-58.4%) | -$317.77M(-6.2%) |
Mar 2024 | - | -$125.47M(+65.1%) | -$338.67M(+5.1%) |
Dec 2023 | -$322.28M(+50.0%) | -$76.00M(+18.6%) | -$322.28M(+5.6%) |
Sep 2023 | - | -$64.06M(-12.4%) | -$305.11M(+5.9%) |
Jun 2023 | - | -$73.13M(-33.0%) | -$288.21M(+9.4%) |
Mar 2023 | - | -$109.08M(+85.4%) | -$263.35M(+22.6%) |
Dec 2022 | -$214.85M(+451.7%) | -$58.84M(+24.8%) | -$214.85M(+14.2%) |
Sep 2022 | - | -$47.16M(-2.3%) | -$188.09M(+64.6%) |
Jun 2022 | - | -$48.27M(-20.3%) | -$114.24M(+79.1%) |
Mar 2022 | - | -$60.59M(+88.9%) | -$63.79M(+63.8%) |
Dec 2021 | -$38.94M(-42.1%) | -$32.08M(-220.2%) | -$38.94M(+32.7%) |
Sep 2021 | - | $26.69M(+1119.2%) | -$29.34M(-47.8%) |
Jun 2021 | - | $2.19M(-106.1%) | -$56.21M(-18.9%) |
Mar 2021 | - | -$35.74M(+59.1%) | -$69.28M(+2.9%) |
Dec 2020 | -$67.31M(-8.8%) | -$22.47M(>+9900.0%) | -$67.31M(+26.3%) |
Sep 2020 | - | -$180.00K(-98.3%) | -$53.31M(-25.4%) |
Jun 2020 | - | -$10.89M(-67.8%) | -$71.47M(-14.0%) |
Mar 2020 | - | -$33.77M(+298.6%) | -$83.08M(+12.6%) |
Dec 2019 | -$73.78M(+65.2%) | -$8.47M(-53.8%) | -$73.78M(+1.4%) |
Sep 2019 | - | -$18.34M(-18.5%) | -$72.74M(+17.0%) |
Jun 2019 | - | -$22.50M(-8.1%) | -$62.14M(+34.7%) |
Mar 2019 | - | -$24.47M(+229.3%) | -$46.14M(+3.3%) |
Dec 2018 | -$44.66M(+576.0%) | -$7.43M(-4.0%) | -$44.66M(+8.9%) |
Sep 2018 | - | -$7.74M(+19.2%) | -$41.02M(+33.1%) |
Jun 2018 | - | -$6.49M(-71.8%) | -$30.82M(+36.9%) |
Mar 2018 | - | -$22.99M(+506.0%) | -$22.50M(+240.7%) |
Dec 2017 | -$6.61M | -$3.79M(-254.0%) | -$6.61M(-52.2%) |
Sep 2017 | - | $2.46M(+35.6%) | -$13.81M(-3.5%) |
Jun 2017 | - | $1.82M(-125.6%) | -$14.31M(-0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2017 | - | -$7.09M(-35.5%) | -$14.45M(+6.8%) |
Dec 2016 | -$13.52M(+78.3%) | -$10.99M(-662.1%) | -$13.52M(+98.9%) |
Sep 2016 | - | $1.96M(+16.2%) | -$6.80M(-39.3%) |
Jun 2016 | - | $1.68M(-127.3%) | -$11.21M(+75.3%) |
Mar 2016 | - | -$6.17M(+44.3%) | -$6.39M(-15.7%) |
Dec 2015 | -$7.58M(-84.8%) | -$4.27M(+74.3%) | -$7.58M(-39.3%) |
Sep 2015 | - | -$2.45M(-137.7%) | -$12.49M(-51.4%) |
Jun 2015 | - | $6.50M(-188.3%) | -$25.69M(-45.5%) |
Mar 2015 | - | -$7.36M(-19.8%) | -$47.14M(-5.4%) |
Dec 2014 | -$49.81M(+115.3%) | -$9.18M(-41.4%) | -$49.81M(-6.0%) |
Sep 2014 | - | -$15.66M(+4.8%) | -$53.01M(+32.5%) |
Jun 2014 | - | -$14.95M(+49.0%) | -$40.02M(+46.7%) |
Mar 2014 | - | -$10.03M(-18.9%) | -$27.29M(+17.9%) |
Dec 2013 | -$23.14M(+488.8%) | -$12.37M(+363.6%) | -$23.14M(+114.8%) |
Sep 2013 | - | -$2.67M(+20.3%) | -$10.77M(+32.9%) |
Jun 2013 | - | -$2.22M(-62.3%) | -$8.10M(+37.7%) |
Mar 2013 | - | -$5.89M(<-9900.0%) | -$5.89M(>+9900.0%) |
Dec 2012 | -$3.93M(>+9900.0%) | - | - |
Nov 2011 | - | $0.00(0.0%) | -$600.00(-14.3%) |
Aug 2011 | - | $0.00(0.0%) | -$700.00(0.0%) |
May 2011 | - | $0.00(-100.0%) | -$700.00(0.0%) |
Feb 2011 | -$700.00(+600.0%) | -$600.00(+500.0%) | -$700.00(+600.0%) |
Nov 2010 | - | -$100.00(<-9900.0%) | -$100.00(<-9900.0%) |
Aug 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
May 2010 | - | $0.00(0.0%) | -$100.00(0.0%) |
Feb 2010 | -$100.00(-99.5%) | $0.00(0.0%) | -$100.00(0.0%) |
Nov 2009 | - | $0.00(-100.0%) | -$100.00(-66.7%) |
Aug 2009 | - | -$100.00(<-9900.0%) | -$300.00(+50.0%) |
May 2009 | - | $0.00(0.0%) | -$200.00(-99.0%) |
Feb 2009 | -$20.20K(<-9900.0%) | $0.00(-100.0%) | -$20.20K(0.0%) |
Nov 2008 | - | -$200.00(<-9900.0%) | -$20.20K(+1.0%) |
Aug 2008 | - | $0.00(-100.0%) | -$20.00K(0.0%) |
May 2008 | - | -$20.00K | -$20.00K |
Feb 2008 | $0.00 | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual FCF year-on-year change?
- What is Travere Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Travere Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM FCF year-on-year change?
What is Travere Therapeutics, Inc. annual free cash flow?
The current annual FCF of TVTX is -$273.69M
What is the all time high annual FCF for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual free cash flow is $0.00
What is Travere Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, TVTX annual free cash flow has changed by +$48.59M (+15.08%)
What is Travere Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of TVTX is -$7.34M
What is the all time high quarterly FCF for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly free cash flow is $26.69M
What is Travere Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, TVTX quarterly free cash flow has changed by +$44.90M (+85.95%)
What is Travere Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of TVTX is -$157.30M
What is the all time high TTM FCF for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM free cash flow is $0.00
What is Travere Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, TVTX TTM free cash flow has changed by +$160.47M (+50.50%)